• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血栓栓塞性疾病作为儿童肾病综合征的一种并发症]

[Thrombo-embolic disease as a complication of nephrotic syndrome in children].

作者信息

Jarmoliński T, Zachwieja J, Bortkiewicz E, Stachowski J, Maciejewski J

机构信息

II Klinika Chorób Dzieci Instytutu Pediatrii Akademii Medycznej w Poznaniu.

出版信息

Pediatr Pol. 1996 May;71(5):437-41.

PMID:8710427
Abstract

Eight children with thrombo-embolic disease in the course of nephrotic syndrome were treated at II Clinic of Children's Diseases (Institute of Pediatrics, Poznań) between 1991 and 1993. The diagnosis was established on the basis of clinical examination and noninvasive imaging techniques. Two patients had an atypical localisation of the thrombus in the left ventricle and right atrium. In laboratory tests of the coagulation system, all of the children had decreased levels of antithrombin III (AT III). All children were treated with heparin and 4 with fibrinolytic agents. AT III concentrate was administered to 3 children. Total resolution of thrombo-embolic disease was obtained in 5 patients, 3 died during treatment. Thrombo-embolic disease should be taken into account in the differential diagnosis of complications of nephrotic syndrome.

摘要

1991年至1993年间,波兹南儿科研究所儿童疾病二科收治了8名患有肾病综合征并伴有血栓栓塞性疾病的儿童。诊断基于临床检查和非侵入性成像技术。两名患者的血栓分别位于左心室和右心房,位置不典型。在凝血系统的实验室检查中,所有儿童的抗凝血酶III(AT III)水平均降低。所有儿童均接受肝素治疗,4名儿童接受了纤溶药物治疗。3名儿童接受了AT III浓缩剂治疗。5名患者的血栓栓塞性疾病完全消退,3名患者在治疗期间死亡。在肾病综合征并发症的鉴别诊断中应考虑血栓栓塞性疾病。

相似文献

1
[Thrombo-embolic disease as a complication of nephrotic syndrome in children].[血栓栓塞性疾病作为儿童肾病综合征的一种并发症]
Pediatr Pol. 1996 May;71(5):437-41.
2
Drugs in the treatment of thrombo-embolic diseases--Part II.用于治疗血栓栓塞性疾病的药物——第二部分。
Ir Med J. 1983 Mar;76(3):155-9.
3
[Plasma and urinary antithrombin III in the nephrotic syndrome in adults].[成人肾病综合征中的血浆及尿液抗凝血酶III]
Ann Med Interne (Paris). 1983;134(8):713-6.
4
Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.肾病综合征中的血栓栓塞并发症:病理生理学与临床管理
Thromb Res. 2006;118(3):397-407. doi: 10.1016/j.thromres.2005.03.030. Epub 2005 Jun 28.
5
[Anomalies of coagulation and thromboembolic complications of nephrotic syndromes].[肾病综合征的凝血异常与血栓栓塞并发症]
Pathol Biol (Paris). 1987 Feb;35(2):195-9.
6
Deep venous thrombosis in children and adolescents.儿童和青少年的深静脉血栓形成
J Neurosurg. 2004 Aug;101(1 Suppl):32-7. doi: 10.3171/ped.2004.101.2.0032.
7
[Hereditary antithrombin III deficiency causing recurrent thrombo-embolic problems (author's transl)].
Nouv Presse Med. 1978 Mar 25;7(12):999-1002.
8
Thrombo-embolism in minimal change nephrotic syndrome.
Southeast Asian J Trop Med Public Health. 1979 Sep;10(3):400-2.
9
Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?用抗凝血酶III预防肾病综合征中的血栓栓塞:为何要进行预防?
Int Urol Nephrol. 2009;41(3):713-6. doi: 10.1007/s11255-008-9434-8. Epub 2008 Aug 12.
10
[Significance of antithrombin III in kidney diseases].[抗凝血酶III在肾脏疾病中的意义]
Behring Inst Mitt. 1986 Feb(79):216-30.

引用本文的文献

1
Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity.
Int Urol Nephrol. 2004;36(4):599-603. doi: 10.1007/s11255-004-0868-3.